Lensar (LNSR) Gross Margin Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -482.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -482.00 |
| Dec 31, 2025 | -2,006.00 |
| Sep 30, 2025 | -342.00 |
| Jun 30, 2025 | -873.00 |
| Mar 31, 2025 | 885.00 |
| Dec 31, 2024 | -2,703.00 |
| Sep 30, 2024 | -27.00 |
| Jun 30, 2024 | -343.00 |
| Mar 31, 2024 | -164,485.00 |
| Dec 31, 2023 | -3,274.00 |
| Sep 30, 2023 | -474.00 |
| Jun 30, 2023 | 1,773.00 |
| Mar 31, 2023 | -806.00 |
| Dec 31, 2022 | -403.00 |
| Sep 30, 2022 | -208.00 |